Beth McCormick (@BethAMcCormick) header
Beth McCormick (@BethAMcCormick) profile picture

Beth McCormick

@BethAMcCormick

Scientist, Innovator, Inventor

 Massachusetts, USA
umassmed.edu/microbiome/
Joined January 2016
  • Tweets57
  • Following125
  • Followers308
Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides difficile rupress.org/jem/article-abst… Check out our recent publication from the Program in Microbiome Dynamics! #microbiome #UMassChan
Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides...

Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides...

The microbial metabolite succinate promotes tuft cell hyperplasia, which enhances the gut’s ability to protect against intestinal infections. This study re

rupress.org
2
104
Fantastic news - congratulations to Victor Ambros @UMassChan and Gary Ruvkun @MGH
UMass Chan Medical School (@UMassChan) profile pictureUMass Chan Medical School
@UMassChan7 Oct 2024
Victor R. Ambros, PhD, @UMassChan's Silverman Chair in Natural Sciences and professor of molecular medicine, has won a Nobel Prize. Media: Email [email protected] for news conference info and interview requests. #NobelPrize #BreakingNews #AdvancingTogether
Congratulations to Nobel Prize winner Victor R. Ambros, PhD, of UMass Chan Medical School

ALT Congratulations to Nobel Prize winner Victor R. Ambros, PhD, of UMass Chan Medical School

1
9
1
85
6,358
UMass Chan Medical School seeks the next generation of scientific leaders! Join our research community as a UMass Chan Early Independence Fellow. Get 3-5 years of support. Apply by Dec 1: academicjobsonline.org/ajo/j… @UMassChan @RTI_UMassChan
Image from Kate Fitzgerald (@FitzgeraldKate)
2
42
3
69
19,887
UMassChan Department of Microbiology MD/PhD student Ben Sallis in the McCormick lab presented his work in a poster at FASEB Gastrointestinal Tract XXI: Life, Death, and Disease on September 9th, 2024!
Image from UMass Chan Department of Microbiology (@UMassChanMicro)
1
2
118
Beth McCormick and Michael Stauff named department chairs umassmed.edu/news/news-archi…
Beth McCormick and Michael Stauff named department chairs

Beth McCormick and Michael Stauff named department chairs

Beth A. McCormick, PhD, has been named the new chair of the Department of Microbiology & Physiological Systems (MaPS), and Michael P. Stauff, MD, has been appointed chair of the Department of...

umassmed.edu
8
2
2
46
2,826
Beth McCormick retweeted
Katie Couric (@katiecouric) profile picture
Katie Couric
@katiecouric4 Jun 2023
So fun giving the commencement address at ⁦@UMassChan⁩ (med school) celebrating these impressive doctors, nurses & scientists! (You may call me “Dr. Katie.”) Thanks for the feedback—my speech will be in Wake-Up Call tomorrow! Sign up at Katiecouric.com 🎓🩻🩺🥼
Image from Katie Couric (@katiecouric)
19
28
4
685
73,907
teapaw.org/DecMcCole/status/16499… @UMassChan
Declan McCole (@DecMcCole) profile pictureDeclan McCole@DecMcCole23 Apr 2023
A poignant and very entertaining talk by the Distinguished Research Award winner Dr. Beth “Bugs” McCormick at the @APSPhysiology GI & Liver Section Banquet. Such a deserving recipient! 👏👏
Image from Declan McCole (@DecMcCole)
1
7
522
GIL Distinguished Award Winner @BethAMcCormick sharing her scientific journey @GIL_trainee #APS2023
Image from Dr. Melanie Gareau (@gareaulab)
2
21
969
Adiso Therapeutics Provides Development Update Reflecting Strong Progress Across Its Pipeline prn.to/3fOQWys It's a privilege for me to share this exciting news from Adiso! A great company backed by a great team!! Way to go!! @Adiso @UMassChan @Inflammation @IBD
Adiso Therapeutics Provides Development Update Reflecting Strong Progress Across Its Pipeline

Adiso Therapeutics Provides Development Update Reflecting Strong Progress Across Its Pipeline

/PRNewswire/ -- Adiso Therapeutics, Inc., a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and improve...

prnewswire.com
Looking for Post-doc fellows with an interest in gut microbe host interactions to join my lab - in a great environment and with terrific colleagues!! #gutmicrobiome #gutmicrobes #microbiome #gastroenterology
1
25
3
31
UMassChan umassmed.edu/news/news-archi… So proud of this team effort!! #UMassChan #COVID19 #microbes
UMass Chan scientists develop web app for visualizing locality of COVID-19 variants, clinical data

UMass Chan scientists develop web app for visualizing locality of COVID-19 variants, clinical data

Led by Doyle Ward, PhD, researchers at UMass Chan Medical School have developed a web application that allows epidemiologists, public health officials and other scientists to access genetic informa...

umassmed.edu
3
Replying to @GIL_trainee @EdelblumLab @squeakyanimal @GI_Distress @gareaulab @KHamiltonPhD @Kathrynated @DecMcCole @keely_stephen @simonkeely @BethAMcCormick @arianne_theiss
Always and forever @GI_Distress gigs!
Image from Dr. Kim E. Barrett (@DrKimEBarrett)
Image from Dr. Kim E. Barrett (@DrKimEBarrett)
Image from Dr. Kim E. Barrett (@DrKimEBarrett)
1
1
1
15
Diet-microbiome interactions are complex! Check out our article in Gut Microbes to learn about first steps in detangling the impact of specific foods on bacterial species commonly depleted in patients with IBD to better inform dietary treatment @almaldonxx doi.org/10.1080/19490976.202…
5
6
Our Program in Microbiome Dynamics at @UMassChan umassmed.edu/pmd/ home of the UMass Center for Microbiome Research is looking for a Senior Scientific Writer to join our team. Here is the job posting: ummsjobs.com/job/7557/ Apply!!!
Program in Microbiome Dynamics

Program in Microbiome Dynamics

Program in Microbiome Dynamics, UMass Chan Medical School, Worcester, MA

umassmed.edu
6
6
Morningside Ventures Launches Adiso Therapeutics to Advance Novel Therapies for Inflammatory Diseases prn.to/3tJ8oI1 Happy to share we are out of stealth mode!!! #inflammation #IBD #ulcerativecolitis #Cdiff #UMassChan
1
6
New research from @UMassChan & @UniofBath brings investigators one step closer to understanding how a good balance of microbes in our guts is linked to the body’s immune system & intestinal health. bit.ly/3DaUbat #microbiome #guthealth #IBD @BethAMcCormick @sage_foley
3
14
Way to go! Another great study from the Program in Microbiome Dynamics #microbiome #COVID19 #UMassChan
UMass Chan Medical School (@UMassChan) profile pictureUMass Chan Medical School
@UMassChan22 Oct 2021
#UMassChan researchers Evan S. Bradley, MD, PhD, & John P. Haran, MD, PhD, have found a clear biological signal associating a change in the oral microbiome w/ long-COVID symptoms. Read about their research: bit.ly/2ZcY7Is #COVID19 #microbiome @JohnPHaran @UMass_Medicine
UMass Chan study finds association between long-COVID symptoms and altered oral microbiome

UMass Chan study finds association between long-COVID symptoms and altered oral microbiome

Research by John P. Haran, MD, PhD, and Evan S. Bradley, MD, PhD, at UMass Chan Medical School, shows that patients with persistent long-COVID symptoms have oral microbiomes with a significantly...

umassmed.edu
1
UMassMedical umassmed.edu/news/news-archi…

Helmsley Charitable Trust grant to fund UMMS IBD diet research

With the funding, Ana Maldonado-Contreras, PhD, will tailor a novel diet created at UMass Medical School to patients in Puerto Rico with different food availability and preferences.

umassmed.edu
5
UMassMedical umassmed.edu/news/news-archi…
New study of oral therapy candidate indicates positive results for patients with mild-to-moderate...

New study of oral therapy candidate indicates positive results for patients with mild-to-moderate...

New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced...

umassmed.edu
10
Bacainn Therapeutics Reports Positive Topline Results from Phase 1 Study of BT051, a Novel Therapeutic Approach to Treat Inflammatory Diseases Such As Ulcerative Colitis | Business Wire businesswire.com/news/home/2…

Bacainn Therapeutics Reports Positive Topline Results from Phase 1 Study of BT051, a Novel Therap...

Bacainn Therapeutics, Inc., a Company developing novel therapies to address uncontrolled inflammation, today announced the successful completion of the compa...

businesswire.com
1
Load more